Search for new drugs to reduce TBI severity continues
Citicoline, an endogenous compound found in neural tissue, has not proven to have the neuroprotective qualities as was hoped prior to the conclusion of the most recent study involving the treatment of individuals with recent TBI. When compared to the placebo-treated group there was little difference from the Citicoline-treated cohort. These studies remain so vital to the need to reduce the neurological consequences of traumatic brain injuries and improve the outcomes available to people with TBI.
We look forward to the development of better methods to reduce injury severity, promote recovery and allow people with brain injuries to experience lower levels of disabilities. Each study offers new hope and the anticipation that disability from brain injury can be reduced.
Click here to read a summary of the study:
Tag lines: Severe Brain Injury Outcomes, TBI Rehabilitation, Citicoline and TBI, neuroprotective drugs